OPVERSE
Live / Applied — Non-final action mailed (as of 06 Mar 2026)
What this means for you
Not registered yet, but its 20 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99452213
- Mark type
- Word mark
- Filed
- 20 Oct 2025
- Attorney of record
- Angel Roman Campos
Goods and services
- Class 042 — Scientific and technological services: Provision of biological research services; Provision of bacteriological research services; Conducting clinical trials for pharmaceutical drugs and reagents; Conducting clinical trial services; Research and analytical services relating to pharmaceutical drugs and reagents; Provision of medical research services; Research and development services in the field of allogeneic stem cell-based pharmaceuticals; Research and development services in the field of cell therapy and Contract Development and Manufacturing Organization (CDMO) solutions
Owner
- NATIONAL TAIWAN UNIVERSITY, Taipei, TW
Prosecution history
- 06 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Mar 2026 — NON-FINAL ACTION E-MAILED
- 06 Mar 2026 — NON-FINAL ACTION WRITTEN
- 06 Mar 2026 — ASSIGNED TO EXAMINER
- 04 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 20 Oct 2025 — NEW APPLICATION ENTERED